Impacts of polypharmacy in young adults using antidepressants: A systematic review
DOI:
https://doi.org/10.33448/rsd-v14i1.47999Keywords:
Young Adults, Drug Interactions, Polypharmacy, Antidepressants, Polymedication.Abstract
Polypharmacy, defined as the concomitant use of five or more medications, is a growing phenomenon, particularly among young adults with psychiatric conditions using antidepressants. This practice, driven by therapeutic guidelines and early diagnoses, is associated with a high risk of adverse drug interactions and significant side effects. Objective: To investigate the impacts of polypharmacy in young adults using antidepressants, focusing on drug interactions and clinical outcomes. Methodology: A systematic review was conducted following PRISMA guidelines. Searches were performed in PubMed, BVS, and Cochrane CENTRAL databases, covering the period from 2019 to 2024, focusing on the relationship between polypharmacy and antidepressant use in young adults. Results: Initially, 61 studies were identified, of which 12 met the inclusion criteria. Reported outcomes included: higher risk of cardiac arrhythmias, increased suicidal ideation and attempts, impaired antidepressant metabolism, hypoglycemia, falls, mortality, gastrointestinal events, reduced treatment adherence, and increased incidence of diabetes mellitus. Women and individuals from lower socioeconomic classes exhibited a higher prevalence of polypharmacy. Conclusion: Polypharmacy among young adults using antidepressants is associated with a range of adverse outcomes, compromising therapeutic efficacy and patient safety. The importance of rigorous monitoring, individualized treatment, and detailed investigation of drug interactions by healthcare professionals is emphasized.
Downloads
References
Al Zaabi, M. S. R., Sridhar, S. B., Rabbani, S. A., Tadross, T. M., Shareef, J., & Shariff, A. (2024). Antidepressant prescription patterns and polypharmacy in outpatient psychiatry: a cross-sectional study. Die Pharmazie, 79(3), 82–90. https://doi.org/10.1691/ph.2024.3663
Brabander, E. Y., Breddels, E., van Amelsvoort, T., van Westrhenen, R., & GROUP Investigators (2024). Clinical effects of CYP2D6 phenoconversion in patients with psychosis. Journal of psychopharmacology (Oxford, England), 38(12), 1095–1110. https://doi.org/10.1177/02698811241278844
Brasil. Ministério da Saúde. Conselho Nacional de Saúde. (2012). Resolução n. 466, de 12 de dezembro de 2012: Aprova diretrizes e normas regulamentadoras de pesquisas envolvendo seres humanos. Diário Oficial da União, 12 dez. 2012.
Chris-Olaiya, A., Palmer, W., Stancampiano, F., Lacy, B., Heckman, M., Chirila, R., Nikpour, N., Mcleod, E., Ryan, T., Maillis, A., Vargas, E., & Bouras, E. (2020). Medication use and polypharmacy in patients referred to a tertiary gastroenterology practice. Romanian journal of internal medicine = Revue roumaine de medecine interne, 58(4), 228–232. https://doi.org/10.2478/rjim-2020-0016
Coutinho, B. (2019). Polifarmácia na atenção básica de saúde (Trabalho de conclusão de curso, Graduação em Medicina, Universidade Federal da Fronteira Sul). Universidade Federal da Fronteira Sul. [S. l.], p. 41-43.
Dell'Osso, B., Albert, U., Carrà, G., Pompili, M., Nanni, M. G., Pasquini, M., Poloni, N., Raballo, A., Sambataro, F., Serafini, G., Viganò, C., Demyttenaere, K., McIntyre, R. S., & Fiorillo, A. (2020). How to improve adherence to antidepressant treatments in patients with major depression: a psychoeducational consensus checklist. Annals of general psychiatry, 19, 61. https://doi.org/10.1186/s12991-020-00306-2
Dołoto, A., Bąk, E., Batóg, G., Piątkowska-Chmiel, I., & Herbet, M. (2024). Interactions of antidepressants with concomitant medications-safety of complex therapies in multimorbidities. Pharmacological reports : PR, 76(4), 714–739. https://doi.org/10.1007/s43440-024-00611-7
Elmowafi, H., Kindblom, J. M., Halldner, L., Gyllenberg, D., & Naumburg, E. (2024). Incidence and trend of cardiac events among children and young adults exposed to psychopharmacological treatment (2006-2018): A nationwide register-based study. British journal of clinical pharmacology, 10.1111/bcp.16321. Advance online publication. https://doi.org/10.1111/bcp.16321
Gomes, I. S. & Caminha, I. O. (2014). Guia para estudos de revisão sistemática: uma opção metodológica para as Ciências do Movimento Humano. Movimento. 20 (1), 395-411.
González-Bueno, J., Sevilla-Sánchez, D., Puigoriol-Juvanteny, E., Molist-Brunet, N., Codina-Jané, C., & Espaulella-Panicot, J. (2022). Improving medication adherence and effective prescribing through a patient-centered prescription model in patients with multimorbidity. European journal of clinical pharmacology, 78(1), 127–137. https://doi.org/10.1007/s00228-021-03207-9
Höhn, A., Jeyam, A., Caparrotta, T. M., McGurnaghan, S. J., O'Reilly, J. E., Blackbourn, L. A. K., McCrimmon, R. J., Leese, G. P., McKnight, J. A., Kennon, B., Lindsay, R. S., Sattar, N., Wild, S. H., McKeigue, P. M., Colhoun, H. M., & Scottish Diabetes Research Network (SDRN) Epidemiology Group (2021). The association of polypharmacy and high-risk drug classes with adverse health outcomes in the Scottish population with type 1 diabetes. Diabetologia, 64(6), 1309–1319. https://doi.org/10.1007/s00125-021-05394-7
Inglis, J. M., Caughey, G., Thynne, T., Brotherton, K., Liew, D., Mangoni, A. A., & Shakib, S. (2024). Association of Drug-Disease Interactions with Mortality or Readmission in Hospitalised Middle-Aged and Older Adults: A Systematic Review and Meta-Analysis. Drugs - real world outcomes, 11(3), 345–360. https://doi.org/10.1007/s40801-024-00432-3
Jeffery, A., Bhanu, C., Walters, K., Wong, I. C. K., Osborn, D., & Hayes, J. F. (2023). Association between polypharmacy and depression relapse in individuals with comorbid depression and type 2 diabetes: a UK electronic health record study. The British journal of psychiatry : the journal of mental science, 222(3), 112–118. https://doi.org/10.1192/bjp.2022.160
Lavigne, J. E., Hur, K., Kane, C., Au, A., Bishop, T. M., & Pigeon, W. R. (2019). Prescription Medications for the Treatment of Insomnia and Risk of Suicide Attempt: a Comparative Safety Study. Journal of general internal medicine, 34(8), 1554–1563. https://doi.org/10.1007/s11606-019-05030-6
Montag, L. J., Horneff, G., Hoff, P., Klein, A., Kallinich, T., Foeldvari, I., Seipelt, E., Tatsis, S., Peer Aries, M. D., Niewerth, M., Klotsche, J., & Minden, K. (2022). Medication burden in young adults with juvenile idiopathic arthritis: data from a multicentre observational study. RMD open, 8(2), e002520. https://doi.org/10.1136/rmdopen-2022-002520
Moreira, T., Alvares-Teodoro, J., Barbosa, M. M., Do Nascimento, R. C. R. M., Guerra Júnior, A. A., & Acurcio, F. A. (2020). Polypharmacy among adult and older adult users of primary care services delivered through the Unified Health System in Minas Gerais, Brazil. Expert review of clinical pharmacology, 13(12), 1401–1409. https://doi.org/10.1080/17512433.2020.1836958
Naizer, H., Wozny, J., Krause, T. M., Huson, E., & Freeman, L. (2024). Trends in central nervous system-active polypharmacy among people with multiple sclerosis. Multiple sclerosis (Houndmills, Basingstoke, England), 30(9), 1139–1150. https://doi.org/10.1177/13524585241251986
Nestsiarovich, A., Kerner, B., Mazurie, A. J., Cannon, D. C., Hurwitz, N. G., Zhu, Y., Nelson, S. J., Oprea, T. I., Crisanti, A. S., Tohen, M., Perkins, D. J., & Lambert, C. G. (2020). Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder. Psychoneuroendocrinology, 112, 104511. https://doi.org/10.1016/j.psyneuen.2019.104511
Ramos, K. A., Colosimo, E. A., Duarte, Y. A. O., & Bof de Andrade, F. (2023). Effect of polypharmacy and Fall-Risk-Increasing Drugs (FRIDs) on falls among Brazilian older adults: The SABE cohort study. Archives of gerontology and geriatrics, 115, 105127. https://doi.org/10.1016/j.archger.2023.105127
Rhee, T. G., & Rosenheck, R. A. (2019). Psychotropic polypharmacy reconsidered: Between-class polypharmacy in the context of multimorbidity in the treatment of depressive disorders. Journal of affective disorders, 252, 450–457. https://doi.org/10.1016/j.jad.2019.04.018
Riffer, F., Farkas, M., Streibl, L., Kaiser, E., & Sprung, M. (2019). Psychopharmacological treatment of patients with borderline personality disorder: comparing data from routine clinical care with recommended guidelines. International Journal of Psychiatry in Clinical Practice, 1–11. doi:10.1080/13651501.2019.1576904
Stassen, H. H., Bachmann, S., Bridler, R., Cattapan, K., Herzig, D., Schneeberger, A., & Seifritz, E. (2022). Detailing the effects of polypharmacy in psychiatry: longitudinal study of 320 patients hospitalized for depression or schizophrenia. European archives of psychiatry and clinical neuroscience, 272(4), 603–619. https://doi.org/10.1007/s00406-021-01358-5
Tiguman, G. M. B., Hoefler, R., Silva, M. T., Lima, V. G., Ribeiro-Vaz, I., & Galvão, T. F.. (2024). Prevalence of antidepressant use in Brazil: a systematic review with meta-analysis. Brazilian Journal of Psychiatry, 46, e20233095. https://doi.org/10.47626/1516-4446-2023-3095
Varimo, E., Saastamoinen, L. K., Rättö, H., & Aronen, E. T. (2023). Polypharmacy in children and adolescents initiating antipsychotic drug in 2008-2016: a nationwide register study. Nordic journal of psychiatry, 77(1), 14–22. https://doi.org/10.1080/08039488.2022.2042597
Verdoux, H., Pambrun, E., Tournier, M., Cortaredona, S., & Verger, P. (2019). Multi-trajectories of antidepressant and antipsychotic use: a 11-year naturalistic study in a community-based sample. Acta psychiatrica Scandinavica, 139(6), 536–547. https://doi.org/10.1111/acps.13020
Wang, Z. Z., Deng, S. H., Lu, H. Y., Li, L., Zhu, X. Q., Hu, J. Q., Xie, H. S., Chen, H. Z., Chen, Y. Q., Zhang, M., Fang, Z. Y., Wen, Y. G., & Shang, D. W. (2020). Effect of venlafaxine dosage, valproic acid concentration, sex, and age on steady state dose-corrected concentrations of venlafaxine and O-desmethylvenlafaxine: A retrospective analysis of therapeutic drug monitoring data in a Chinese population. Human psychopharmacology, 35(3), e2733. https://doi.org/10.1002/hup.2733
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Débora Sinara Paulino; Leonardo Carvalho de Sousa; Ana Beatriz de Castro Sobrinho; Glenda Glayce Pereira Rodrigues; Lorenna Lúcio Lacerda ; Andre Rodrigues Ataide; Lavynia Ferreira Nunes; Ana Beatriz Scarparo Pereira; Daniella Cristina Silva Xavier
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
1) Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
2) Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
3) Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
